EN

Activated dimethicone/magaldrate

Quick links

Choose a section

Quick links to important sections

Advertisements

Activated dimethicone/magaldrate

Activated dimethicone_magaldrate_EN
Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Activated dimethicone/magaldrate

Defining Activated Dimethicone/Magaldrate: Class and Composition

Activated dimethicone/magaldrate is a non-prescription combination product used to address discomfort in the gastrointestinal tract, simultaneously classified as both an antacid and an antiflatulent. This medicinal entity is taken via the oral route of administration and is typically found as an oral suspension or in tablet form. The preparation contains two distinct active ingredients: Magaldrate, which functions as the primary acid-neutralizing agent, and Activated Dimethicone, which manages gas-related issues. This combination is intended for managing upper digestive symptoms.

The Synthetic Origin and Nature of the Components

Both primary components in this preparation are of synthetic origin, each performing a specialized, localized function. Magaldrate is a complex chemical entity, structured as a refined combination of aluminum and magnesium compounds designed for efficient gastric acid neutralization. This component is recognized for its controlled and sustained buffering capacity. The second component, Activated Dimethicone, is a modified silicone polymer, Polydimethylsiloxane, which is non-systemic and chemically inert. The antifoaming action of Activated Dimethicone lowers the surface tension of gas bubbles, causing them to coalesce, which aids in alleviating symptoms related to excess intestinal gas.

General Therapeutic Purpose and Foundational Benefit

Activated dimethicone/magaldrate is commonly used when a patient experiences a feeling of bloating or pressure alongside the burning sensation of hyperacidity—a frequent combination after consuming a heavy meal. The general therapeutic purpose is to provide simultaneous symptomatic relief by targeting two core sources of acute upper gastrointestinal distress. The Magaldrate component helps manage discomfort associated with sour stomach, while the Activated Dimethicone simultaneously reduces uncomfortable pressure and feelings of fullness caused by trapped gas. This dual action provides a foundational benefit for restoring comfort in the digestive tract.

Advertisements

What side effects are possible with Activated dimethicone/magaldrate?

Possible Side Effects and Safety Information

The safety profile for magaldrate in combination with activated dimethicone (simethicone) is based on official government regulatory documents and centers on gastrointestinal effects and the potential for mineral imbalance and toxicity.

Adverse Reactions by Frequency

Official regulatory labels classify certain side effects based on how often they may occur:

  • Uncommon: Diarrhea, Constipation.
  • Frequency Not Known: Abdominal pain, Hyperaluminemia (increased aluminum in the blood), Hypophosphatemia (low phosphate levels).

Serious Adverse Reactions and Systemic Risks

The most serious safety concerns are typically associated with high doses or use in individuals with underlying conditions, particularly kidney impairment.

  • Mineral/Electrolyte Imbalance: Risk of Hypermagnesemia (high magnesium) and Hyperaluminemia in patients with reduced kidney function, as the body cannot clear these metal components efficiently.
  • Phosphate Depletion: Prolonged or high-dose use of aluminum-containing antacids can lead to Hypophosphatemia and potentially lead to bone disorders like osteomalacia.
  • Intestinal Obstruction: Large doses may trigger or worsen intestinal obstruction or ileus, especially in the elderly or those with impaired kidney function.
  • Long-Term Toxicity: In patients with renal failure, long-term exposure to high doses of the metal salts has been associated with severe outcomes, including encephalopathy (brain disease), dementia, and certain types of anemia.

Safety Restrictions and Warnings

  • Contraindications: This medicine is typically contraindicated (must not be used) in cases of severe kidney failure and in individuals with a known history of hypophosphatemia or hypersensitivity to the ingredients.
  • Drug Interactions: The medicine may interfere with the absorption of many other oral medicines; therefore, regulatory guidance recommends not taking this product within one hour of taking other oral medications.
Advertisements

Overdose and Emergency Response

Excessive ingestion of Activated dimethicone/magaldrate is officially linked to two categories of risk. Acute overdose may result in significant gastrointestinal distress, presenting primarily as severe diarrhoea, abdominal pain, and vomiting. The regulatory mandate is to seek immediate medical attention upon suspicion of any overdose.

The most serious documented risks are associated with chronic high-dose exposure, particularly in individuals with pre-existing renal impairment. When component clearance is diminished, the accumulation of aluminum and magnesium ions can lead to Hyperaluminemia and Hypermagnesemia. These systemic manifestations pose risks for severe outcomes like encephalopathy and microcytic anaemia, as noted in official prescribing information.

Official labeling also describes the risk of severe complications such as intestinal obstruction and ileus following high doses, especially in elderly patients. Contacting emergency services immediately is required if the exposed individual has a known renal function deficiency. Treatment for all overdose scenarios is defined as symptomatic and supportive, and it is officially documented that no specific antidote is known for this combination product. Management may involve hospital monitoring and specialized procedures, such as forced diuresis or haemodialysis, depending on the severity of ion accumulation.

Advertisements

Therapeutic Uses of Activated dimethicone/magaldrate

What Activated Dimethicone/Magaldrate Treats: Main Uses and Benefits

The uses for this combination are established for providing symptomatic relief across key therapeutic domains. These preparations are relevant for addressing specific gastrointestinal discomforts.

Support for Combined Symptom Domains

This medication is applied across domains where additional symptomatic support is needed, primarily managing hyperacidity and trapped gas simultaneously. It is commonly used across conditions presenting with acute episodes, and may be part of symptomatic management in conditions marked by increased discomfort such as Gastritis, sour stomach, Gastroesophageal Reflux Disease (GERD), and episodes involving gas-related distension. The product assists the patient during difficult episodes by helping ease distress and is generally used to help address symptom clusters that interfere with daily comfort.

“The product is relevant for easing symptoms related to physical discomfort, which may assist with maintaining functional stability.”

Quick Fact: Purpose is Symptomatic Support for Simultaneous Heartburn and Bloating

Primary Therapeutic Benefit

This combination is applied across domains to provide dual symptomatic support, contributing to easing the overall symptom load during periods of heightened symptoms. It is relevant for helping ease symptoms related to the burning pain of acid irritation, as well as the abdominal pressure and fullness caused by gas accumulation.

Regulatory References

  1. Health Canada Antacid Labelling Standard
Advertisements

Eligibility and Restrictions for Use

The official regulatory profile for Activated dimethicone/magaldrate strictly defines eligible populations by focusing on existing health conditions and age-based safety data.

Eligibility Scope

| Populations for whom use is allowed (as stated in label): | Adults and children ge 12 years old. | Populations for whom use is contraindicated: | Patients with known hypersensitivity to any component; severe renal failure; hypophosphataemia; or intestinal obstruction.

Age-related Eligibility Rules

Safety and efficacy are generally not established for children under 12 years of age; use is restricted to adolescents and adults. Older adults may use the normal adult dose, but caution is advised with prolonged use.

Condition-specific Eligibility Rules

The medicine requires caution in patients with non-severe renal or hepatic impairment due to the risk of systemic aluminum and magnesium accumulation; prolonged use in these populations should be avoided. Use during pregnancy and lactation is documented as requiring caution and is generally recommended only when the benefit clearly outweighs potential risk.

Eligibility Classifications (High-Level)

| Eligibility severity classification (as defined in official documents): | Contraindicated, Safety/Efficacy Not Established, Use with Caution. | Regulatory basis (EMA / FDA / etc.): | Official prescribing information (SmPC/Prescribing Information).

Connection to the overall eligibility profile

Official regulatory documents define eligibility by setting absolute prohibitions for populations with compromised kidney function or allergies. They mandate restrictions based on age due to insufficient data and require conditional use rules for altered physiological states like pregnancy, thereby defining a narrow population for whom standard use is intended.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The primary interaction mechanism for magaldrate is the reduction of absorption of co-administered oral medications in the gastrointestinal tract. This effect is a result of the product's high buffering capacity and its ability to bind to other drugs, which can lead to reduced efficacy of the interacting medicine.

Documented Interacting Medicinal Products and Categories

Official regulatory information requires caution or a time-separation rule when using this product with several categories of medicines that depend on adequate gastrointestinal absorption. These include:

  • Antibiotics: Specifically, agents like tetracyclines and fluoroquinolones (e.g., Ciprofloxacin, Norfloxacin, Doxycycline) are known to form complexes with the aluminum and magnesium components.
  • Other Drugs: The absorption of medications such as digoxin, thyroid hormones, bisphosphonates (e.g., alendronic acid), phenytoin, and certain antivirals (e.g., Raltegravir) may be significantly reduced.

Timing-Based Interaction Constraint

To mitigate the risk of reduced absorption and maintain the expected efficacy of other oral medicines, a specific procedural constraint is required: The administration of this product must be separated by an interval of at least two hours before or after the intake of other oral medicines.

Population-Specific Note

Caution is warranted in patients with renal impairment or kidney disease. Due to the presence of aluminum and magnesium salts, there is a risk of systemic accumulation of these electrolytes, which can lead to adverse effects in individuals with reduced renal clearance.

Advertisements

Mechanism of Action

Chemical Neutralization of Gastric Acidity

This domain covers the action of Magaldrate, which functions as a chemical buffering agent that targets excess gastric hydrochloric acid ( HCl). By rapidly consuming hydrogen ions ( H^+), the mechanism increases the intragastric pH environment and causes the inactivation of the proteolytic enzyme Pepsin, thereby lessening the corrosive activity on the stomach lining. Magaldrate further contributes by forming a physical barrier through a gel-like layer .

Physical Dynamics of Antifoaming Action

This domain focuses on the distinct mechanism of Activated Dimethicone, a non-absorbed surfactant that physically targets the surface tension of stable foam bubbles within the gastrointestinal lumen. This effect causes small, trapped bubbles to coalesce into larger gas pockets that are more easily mobilized and expelled, leading to the dissipation of mechanical force caused by the foam.

Integrated Peripheral Synergy

The overall effect arises from the complementary dual action of the components. This coordinated, entirely peripheral mechanism simultaneously targets two distinct physiological factors in the upper GI environment: chemical acidity and mechanical luminal pressure.

Advertisements

Dosage and Administration Information

How to Use Activated dimethicone/magaldrate

This section outlines the general principles for the administration of activated dimethicone/magaldrate, focusing on usage patterns and dose structure.

Administration Guidelines

Guideline Entity Standard Application
Route and Form The medicine is intended for the oral route, available as an oral suspension or chewable tablets.
Standard Dosing The typical adult single dose ranges from 5 mL to 10 mL of the liquid form, or the equivalent tablet strength, taken to relieve acute symptoms.
Frequency and Timing Administration is generally on an as-needed (pro re nata) basis, typically scheduled for 1 to 2 hours after main meals and at bedtime. Total daily intake is subject to a maximum limit.
Preparation The oral suspension must be shaken well immediately before measurement, and chewable tablets must be thoroughly chewed prior to swallowing.

Usage Constraints and Duration

Specific procedural and temporal constraints apply to the use of this medication. A 1- to 2-hour interval should be observed between the administration of this antacid combination and other oral medications to prevent interference with drug absorption. For unsupervised self-treatment, the usage protocol is restricted to a maximum of 14 consecutive days; use beyond this period requires professional evaluation. While used in older adults at standard doses, long-term, high-dose use is cautioned against in individuals with renal impairment.

This structured usage protocol defines the standardized, short-term application of activated dimethicone/magaldrate for acute episodes.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Activated Dimethicone/Magaldrate

Evidence for Use in Heartburn and Acid Reflux

Activated dimethicone/magaldrate was studied for its use in conditions associated with acute or disruptive episodes like heartburn and symptoms of acid reflux. Research in this area focused on episodes where symptoms become more noticeable and examined outcomes related to physical discomfort during those periods to see how patients reported changes in heartburn and acid reflux symptoms.

Studies in this area often used research exploring short-term symptom changes to monitor how patient-reported experiences evolved after use. Research explores the patterns measured during the study period, specifically patient-reported outcomes describing perceived discomfort tracked over defined time intervals. Research has monitored how participant reports of outcomes capturing phases of heightened symptom activity evolved.

However, the follow-up durations were limited in many of these studies. This means that while research provides context for patterns observed during short time intervals, there is limited information for long-term outcomes regarding repeated or sustained exposure in studies concerning heartburn and acid reflux. More research is ongoing to better understand its role in conditions characterized by fluctuating or episodic manifestations.

Evidence for Use in Indigestion ( Dyspepsia)

Research examined Activated dimethicone/magaldrate in individuals with general indigestion (also known as dyspepsia) and associated symptoms like bloating and gas. This research was evaluated in studies tracking outcomes related to systemic or functional imbalance in the digestive tract. The content will summarize how research describes patterns observed during short time intervals for these common stomach acid-related issues.

In studies where participants reported symptoms of indigestion and gas, the product was observed in trials assessing short-term or episodic symptom patterns. Findings describe patterns observed in the studies where patient-reported outcomes describing perceived discomfort related to bloating were measured. Some data show patterns related to how outcomes related to systemic or functional imbalance evolved during the short study periods.

Studies describe that the results apply only to the populations studied and reflect the specific conditions under which they were conducted. For some outcomes related to systemic or functional imbalance, the findings were mixed, and the evidence quality varies across studies. More research is ongoing to provide clearer context for its role across all aspects of indigestion.

Key Studies & References

  1. Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Activated dimethicone/magaldrate (FAQ)

Q: How should I store the liquid or tablet form of this drug?

Regulatory documents state that products should generally be kept at controlled room temperature, which is typically between 20 C and 25 C (68 F and 77 F). It is important that the medicine be stored in a way that protects it from freezing temperatures.

Q: What specific categories of medicines are known to interact with magaldrate or dimethicone?

Official information indicates that this medicine may interact with certain drug categories due to potential interference with absorption. These categories include some antibiotics, certain thyroid hormones, iron supplements, and some multivitamin preparations. Regulatory labeling often specifies that a time interval must be observed between administrations to manage this risk.

Q: Can taking Activated dimethicone/magaldrate affect the effectiveness of other medications I take?

Official guidelines state that taking this antacid near the time of other oral medications may interfere with how those drugs are absorbed into the body. This interference could potentially make your other medications less effective. Official instructions typically advise that a mandatory time interval must be observed between doses.

Q: Can this medicine cause aluminum toxicity or change phosphate levels in the body?

Official documents advise caution for individuals with pre-existing kidney impairment. Magaldrate contains aluminum, and its components can be absorbed, due to the potential for aluminum absorption, which requires caution in populations with impaired kidney function.

Q: Does Activated dimethicone/magaldrate treat both acid and gas at the same time?

Yes, official labeling indicates the product is designed to relieve symptoms caused by both excess stomach acid and gas. The magaldrate component addresses symptoms like heartburn, while the activated dimethicone component addresses gas symptoms like pressure and bloating.

Q: What are the main active ingredients in this medicine?

The primary active ingredients are magaldrate, which is a compound of aluminum and magnesium hydroxides, and activated dimethicone (also known as simethicone). Magaldrate functions as an antacid, and activated dimethicone functions as an anti-flatulent agent.

Q: Is Activated dimethicone/magaldrate considered an over-the-counter (OTC) drug in most places?

Regulatory labeling for certain products containing this combination provides self-treatment instructions and duration limits without requiring a prescription. These characteristics are consistent with the classification of non-prescription (over-the-counter) medicines.

Q: Is it possible to become dependent or 'addicted' to using this combination drug?

Official safety information provided by regulatory agencies indicates that this combination medicine is not considered to be habit-forming.

Q: Are there any long-term effects of using Activated dimethicone/magaldrate regularly?

Official documents place a restriction on unsupervised use, limiting it to a maximum of 14 consecutive days. Regulatory documents indicate that use extending beyond this period requires medical evaluation.

Q: Why is magaldrate sometimes combined with dimethicone?

The two active components are combined to provide dual-action relief. Magaldrate neutralizes excess stomach acid to address heartburn and sour stomach, while dimethicone is included specifically to break down gas bubbles, thereby helping with bloating and pressure.

Q: What are the most commonly reported side effects people experience?

Commonly reported side effects listed in official documents primarily relate to the gastrointestinal system. These include changes in bowel habits, which may manifest as mild constipation or diarrhea, and sometimes a temporary chalky taste in the mouth.

Q: Can Activated dimethicone/magaldrate cause changes in bowel movements, like constipation or diarrhea?

Yes, changes in bowel movements are listed as possible effects of the medicine. These typically include mild constipation or diarrhea, which are often listed as less serious side effects.

Q: Is there a chalky or unpleasant taste associated with the liquid form?

A chalky taste in the mouth is listed in official documentation as a reported side effect. This is generally considered a minor side effect that does not typically require specific medical intervention.

Q: Can Activated dimethicone/magaldrate be used to manage symptoms of GERD (Gastroesophageal Reflux Disease)?

Official literature indicates this combination is used for managing symptoms associated with various gastrointestinal issues that involve excess acid. This includes heartburn and symptoms related to gastroesophageal reflux disease (GERD).

Q: What medical conditions would prevent someone from being able to use this medication?

Official labeling states that consultation with a medical professional is necessary if certain conditions are present. These conditions include severe kidney disease, known allergies to the product components, stomach ulcers, or intestinal blockage.

Q: Is this medicine safe for people with kidney problems?

Official labeling specifically instructs individuals with kidney disease to consult a doctor before using the product. This caution is advised due to the composition of the active ingredients and the importance of healthy kidney function in their elimination.

Q: Can pregnant women use Activated dimethicone/magaldrate?

The use of this medicine during pregnancy is described as requiring caution. It is generally recommended only after a health professional has determined that the benefit of use outweighs any potential risk to the fetus.

Q: Is Activated dimethicone/magaldrate safe for use while breastfeeding?

Official sources typically state that consultation with a health professional is advised for nursing mothers. While dimethicone is generally not absorbed by the body, information regarding the excretion of magaldrate components into human milk is limited.

Q: What is the general age range for people who can safely use this combination drug?

Regulatory information indicates this medication is generally intended for use in adults and children 12 years of age or older. Official documents state that safety and effectiveness data for use in children younger than 12 years have not been established in the product labeling.

Q: Does magaldrate or dimethicone contain aluminum, and is that a concern?

Yes, magaldrate is a compound that contains aluminum. Official documents caution against long-term, high-dose use for patients with pre-existing kidney impairment, due to the potential for aluminum absorption, which is a factor of caution in that population.

Q: How does the medicine change gas bubbles to relieve bloating?

The dimethicone component is described as an anti-flatulent agent that works to change the surface tension of gas bubbles in the gut. This mechanism helps the small bubbles combine into larger ones, which allows them to be eliminated from the body more easily.

Q: What does 'Activated dimethicone' mean compared to just dimethicone or simethicone?

In the context of antacid products, 'Activated dimethicone' is a term often used synonymously with simethicone. Both terms refer to the specific type of anti-flatulent agent that is included in the medicine to address symptoms of gas and bloating.

Q: Are there any known food or drink items that should be avoided while taking it?

Official warnings advise against consuming alcohol while using this medicine. This is because alcohol consumption can stimulate the production of stomach acid, which may potentially counteract the medicine's effect or increase symptoms.

Q: Can this medication cause any changes to my appetite?

Loss of appetite is listed in official documentation as a reported side effect. Severe or ongoing loss of appetite is listed as a serious side effect that requires a medical consultation.

Q: Is this combination medicine used for stomach ulcers?

Official product information indicates that this medication is used to help relieve symptoms associated with peptic ulcers and gastritis, in addition to other conditions that cause discomfort related to excess stomach acid.

Q: What is the official definition of the drug's purpose according to regulatory documents?

The official purpose of the drug, as defined in regulatory labeling, is the relief of symptoms related to excess stomach acid and gas. These symptoms include acid indigestion, heartburn, sour stomach, upset stomach, and pressure or bloating.

Q: Does Activated dimethicone/magaldrate have an impact on sleep or energy levels?

Official side effect warnings list feeling unusually weak or tired as a potential symptom in certain cases. Official warnings suggest seeking medical consultation if severe weakness or tiredness persists.

Q: Are there any studies available about the use of this medicine in children?

Regulatory documents indicate that the medication is specifically intended for use in adults and children 12 years of age and older. The product labeling explicitly states that safety and effectiveness data for children younger than 12 years are not established.

Q: Does Activated dimethicone/magaldrate interact with common minerals or vitamins?

Yes, official interaction lists include certain vitamins and minerals, such as Vitamin D and multivitamin/mineral preparations. The product may interfere with the body's absorption of these supplements. Regulatory guidelines typically address the timing of administration to manage this interaction.

Q: Will I need a prescription to buy Activated dimethicone/magaldrate products?

Regulatory labeling typically provides instructions for short-term self-treatment with maximum duration limits. This type of information is consistent with the characteristics of over-the-counter (non-prescription) medicines, allowing for purchase without a prescription.

Q: Can Activated dimethicone/magaldrate cause allergic reactions, and what are the signs?

Allergic reactions are a possibility with any medication. Official warnings list signs such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat as symptoms that regulatory warnings list as reasons to discontinue use and seek immediate medical consultation.

Q: Can Activated dimethicone/magaldrate cause light-colored stools?

Light-colored stools are listed in official documents as a less serious side effect that may be experienced while using the medication. This is a recognized change that does not typically require emergency medical care.

Q: Does this medicine contain sodium, and is that a concern for people on a low-sodium diet?

Yes, certain formulations of the medicine contain a small amount of sodium. Official labeling advises individuals who are on a sodium-restricted diet to consult with a health professional before using the product.

Q: Is this medicine helpful for chronic indigestion or just temporary relief?

The drug is regulated for short-term, acute symptom relief. Unsupervised self-treatment is typically restricted to a maximum of 14 days. Any need for use extending beyond this period is defined in regulatory documents as requiring medical evaluation.

Q: Can this drug affect the results of certain medical tests like X-rays or scans?

Official warnings note that this medication may cause unusual or misleading results with certain medical tests. This specifically applies to procedures such as X-rays, CT scans, or MRIs that require the use of a radioactive dye.

Q: What should I do if my symptoms do not improve after using the medicine?

Official guidelines instruct the user to stop taking the medicine if symptoms persist for more than 2 weeks, do not improve, or worsen. Consulting a doctor is advised to allow for proper evaluation of the underlying symptoms.

Q: What are the signs of taking too much of this medicine (overdose symptoms)?

Signs of taking too much of the medicine, as listed in product information, primarily involve severe gastrointestinal discomfort. These symptoms may include severe stomach pain, cramps, severe constipation, or severe diarrhea.

Q: Can I take Activated dimethicone/magaldrate if I also take a thyroid hormone medicine?

Yes, official warnings list thyroid hormones as a class of medicine that may interact with this product. This interaction is usually related to the antacid component potentially affecting the thyroid medicine's absorption and, therefore, its effectiveness.

Q: Are there different strengths of Activated dimethicone/magaldrate available?

Yes, official labeling information confirms that this medicine is available in various strengths and unit concentrations across different commercial products. These differences in concentration are based on the intended market and regulatory standards.

Q: Can this drug cause stomach cramps or abdominal pain?

Severe stomach pain or cramps are listed in official warnings as a symptom that requires immediate medical consultation. Regulatory warnings indicate that severe stomach pain or cramps necessitate immediate medical consultation.

Q: Is it true that this type of antacid can interfere with the absorption of antibiotics?

Yes, official interaction lists specify that this product may interfere with the absorption of certain antibiotics, such as quinolones and tetracyclines. Due to this, a required time interval between administrations is specified in the usage guidelines.

Q: Does taking this medicine affect driving or operating machinery?

Official safety advice generally states that this medication does not affect an individual's ability to drive or operate machinery, meaning it is not associated with effects like sedation or impaired focus.

Advertisements

How should Activated dimethicone/magaldrate be stored and disposed of?

Activated dimethicone/magaldrate should be stored in the container it came in, with the lid tightly closed, and kept out of the reach of children. Store the medication at room temperature, typically between 15 C and 30 C (59 F and 86 F). It is essential to protect the medicine from heat, direct light, and moisture, and do not freeze any liquid formulations.

Disposal

To safely dispose of this medication, follow the instructions provided on the packaging or consult your pharmacist or local waste disposal company for guidance. Do not flush this medicine down the toilet or pour it into a drain unless specifically instructed to do so. It is crucial to ensure that unused or expired medicine is disposed of in a manner that prevents consumption by pets, children, or other people.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Activated dimethicone/magaldrate found in:

A-Z Index: